interstitial lung diseases Archives

Home interstitial lung diseases

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Gian Luca Erre MD, PhD, Arduino Aleksander Mangoni MD

Article Type

Editorial

Published

15 Jan 2021

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases

Valeria Nucera MD, Elisabetta Gerratana MD, Manuela Giallanza MD, Laura La Corte MD, Donatella Sangari MD, Fabiola Atzeni MD, PhD

Article Type

Review

Published

15 Jan 2021

This review focuses on cyclophosphamide due to its crucial role in the treatment of systemic sclerosis-related interstitial lung disease, particularly in the case of patients with progressive Interstitial lung diseases.